Nasdaq:US$18.31 (-0.90) | HKEX:HK$29.35 (-1.20) | AIM:£2.73 (-0.13)
News & Presentations
Previous Article   |   Next Article
Presentations, Scientific Publications | 27 Sep 2015

ESMO 2015: Phase II trial of fruquintinib in metastatic colorectal cancer

1 items
View PDF